Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Other Non-Current Liabilities (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $170000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities fell 42.37% year-over-year to $170000.0, compared with a TTM value of $170000.0 through Sep 2025, down 42.37%, and an annual FY2025 reading of $22000.0, down 99.12% over the prior year.
  • Other Non-Current Liabilities was $170000.0 for Q3 2025 at Roivant Sciences, down from $228000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $21.9 million in Q1 2022 and bottomed at $22000.0 in Q1 2025.
  • Average Other Non-Current Liabilities over 5 years is $7.5 million, with a median of $8.2 million recorded in 2022.
  • The sharpest move saw Other Non-Current Liabilities soared 168.37% in 2022, then tumbled 99.12% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $8.2 million in 2021, then surged by 162.68% to $21.5 million in 2022, then tumbled by 79.38% to $4.4 million in 2023, then tumbled by 93.07% to $307000.0 in 2024, then plummeted by 44.63% to $170000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for ROIV at $170000.0 in Q3 2025, $228000.0 in Q2 2025, and $22000.0 in Q1 2025.